These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 24431196)
1. Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. Raverot G; Jouanneau E; Trouillas J Eur J Endocrinol; 2014 Apr; 170(4):R121-32. PubMed ID: 24431196 [TBL] [Abstract][Full Text] [Related]
2. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390 [TBL] [Abstract][Full Text] [Related]
3. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Buurman H; Saeger W Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [TBL] [Abstract][Full Text] [Related]
5. [Endocrinological evaluation of sellar and suprasellar tumor cases (the 2nd report);--on postoperative pituitary function (author's transl)]. Uozumi T; Mori S; Watanabe M; Takimoto N; Mogami H No Shinkei Geka; 1976 Jan; 4(1):73-8. PubMed ID: 176607 [TBL] [Abstract][Full Text] [Related]
6. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852 [TBL] [Abstract][Full Text] [Related]
8. [Endocrinological evaluation of sellar and suprasellar tumor cases (author's transl)]. Mori S; Uozumi T; Watanabe M; Takimoto N; Mogami H No Shinkei Geka; 1976 Mar; 4(3):235-42. PubMed ID: 179027 [TBL] [Abstract][Full Text] [Related]
9. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Trouillas J; Roy P; Sturm N; Dantony E; Cortet-Rudelli C; Viennet G; Bonneville JF; Assaker R; Auger C; Brue T; Cornelius A; Dufour H; Jouanneau E; François P; Galland F; Mougel F; Chapuis F; Villeneuve L; Maurage CA; Figarella-Branger D; Raverot G; ; Barlier A; Bernier M; Bonnet F; Borson-Chazot F; Brassier G; Caulet-Maugendre S; Chabre O; Chanson P; Cottier JF; Delemer B; Delgrange E; Di Tommaso L; Eimer S; Gaillard S; Jan M; Girard JJ; Lapras V; Loiseau H; Passagia JG; Patey M; Penfornis A; Poirier JY; Perrin G; Tabarin A Acta Neuropathol; 2013 Jul; 126(1):123-35. PubMed ID: 23400299 [TBL] [Abstract][Full Text] [Related]
10. Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor. Scheick S; Amdur RJ; Kirwan JM; Morris CG; Mendenhall WM; Roper S; Friedman W Am J Clin Oncol; 2016 Feb; 39(1):49-54. PubMed ID: 25007040 [TBL] [Abstract][Full Text] [Related]
11. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma. Tinnel BA; Henderson MA; Witt TC; Fakiris AJ; Worth RM; Des Rosiers PM; Edmondson JW; Timmerman RD; Lo SS Stereotact Funct Neurosurg; 2008; 86(5):292-6. PubMed ID: 18758206 [TBL] [Abstract][Full Text] [Related]
12. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly? Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687 [TBL] [Abstract][Full Text] [Related]
13. Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay. Yamada S; Asa SL; Kovacs K; Muller P; Smyth HS J Clin Endocrinol Metab; 1989 Jan; 68(1):73-80. PubMed ID: 2535851 [TBL] [Abstract][Full Text] [Related]
14. [Pituitary adenoma calcification]. Kurisaka M; Mori K; Tindall GT; Takei Y No To Shinkei; 1986 Dec; 38(12):1187-95. PubMed ID: 3028453 [TBL] [Abstract][Full Text] [Related]
15. Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives. Cuny T; Barlier A; Feelders R; Weryha G; Hofland LJ; Ferone D; Gatto F Ann Endocrinol (Paris); 2015 Feb; 76(1):43-58. PubMed ID: 25556152 [TBL] [Abstract][Full Text] [Related]
16. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy. Hagen C; Schroeder HD; Hansen S; Hagen C; Andersen M Eur J Endocrinol; 2009 Oct; 161(4):631-7. PubMed ID: 19654234 [TBL] [Abstract][Full Text] [Related]
17. In search of a prognostic classification of endocrine pituitary tumors. Trouillas J Endocr Pathol; 2014 Jun; 25(2):124-32. PubMed ID: 24839229 [TBL] [Abstract][Full Text] [Related]
18. The hormonal effects of pituitary surgery and irradiation: a review of 59 cases. Wittert G; Donald RA; Espiner EA; Livesey JH; Fox H N Z Med J; 1985 Feb; 98(773):93-7. PubMed ID: 2983273 [TBL] [Abstract][Full Text] [Related]
19. Pathology of invasive pituitary tumors with special reference to functional classification. Scheithauer BW; Kovacs KT; Laws ER; Randall RV J Neurosurg; 1986 Dec; 65(6):733-44. PubMed ID: 3095506 [TBL] [Abstract][Full Text] [Related]
20. Morphology of a plurihormonal human pituitary adenoma composed of FSH, LH and TSH cells. Taşcă C Morphol Embryol (Bucur); 1988; 34(3):189-94. PubMed ID: 2972924 [No Abstract] [Full Text] [Related] [Next] [New Search]